TY - JOUR
T1 - Ligand-directed signaling at the beta3-adrenoceptor produced by 3-(2-ethylphenoxy)-1-[(1,S)-1,2,3,4-tetrahydronapth-1-ylamino]-2S-2-propanol oxalate (SR59230A) relative to receptor agonists
AU - Sato, Masaaki
AU - Horinouchi, Takahiro
AU - Hutchinson, Dana Sabine
AU - Evans, Bronwyn Anne
AU - Summers, Roger James
PY - 2007
Y1 - 2007
N2 - This study examines signaling pathways activated by the mouse beta3-adrenoceptor (AR) expressed in Chinese hamster ovary cells at high (CHObeta3H) or low (CHObeta3L) levels. Functional responses included extracellular acidification rate (ECAR), cyclic AMP accumulation, and p38 MAPK or Erk1/2 phosphorylation. (-)-Isoproterenol and the beta3-AR agonist CL316243 caused concentration-dependent increases in cAMP accumulation and ECAR in CHObeta3H and CHObeta3L cells. For cAMP accumulation, the beta3-AR ligand SR59230A was a partial agonist in CHObeta3H and an antagonist in CHObeta3L cells but for ECAR was an agonist at both expression levels. This suggested that SR59230A which is normally regarded as an antagonist can selectively activate pathways leading to ECAR. Examination of the pathways stimulated by (-)-isoproterenol, CL316243 and SR59230A for both ECAR and cAMP accumulation suggested that the cAMP pathway predominates in CHObeta3H cells while p38 MAPK is a major contributor to ECAR in CHObeta3L cells and was the sole contributor to responses to SR59230A. Western blots of p38 MAPK and Erk1/2 phosphorylation confirmed that MAPKs are activated in CHObeta3H and CHObeta3L cells by CL316243 and SR59230A but that SR59230A has much higher efficacy. In addition, p38 MAPK phosphorylation displayed differences in drug potency and efficacy between CHObeta3H and CHObeta3L cells related to inhibition of the response by cAMP. Thus CL316243 and SR59230A display reversed orders of efficacy for cAMP accumulation compared to Erk1/2 and p38 MAPK phosphorylation providing a strong indication of ligand-directed signaling.
AB - This study examines signaling pathways activated by the mouse beta3-adrenoceptor (AR) expressed in Chinese hamster ovary cells at high (CHObeta3H) or low (CHObeta3L) levels. Functional responses included extracellular acidification rate (ECAR), cyclic AMP accumulation, and p38 MAPK or Erk1/2 phosphorylation. (-)-Isoproterenol and the beta3-AR agonist CL316243 caused concentration-dependent increases in cAMP accumulation and ECAR in CHObeta3H and CHObeta3L cells. For cAMP accumulation, the beta3-AR ligand SR59230A was a partial agonist in CHObeta3H and an antagonist in CHObeta3L cells but for ECAR was an agonist at both expression levels. This suggested that SR59230A which is normally regarded as an antagonist can selectively activate pathways leading to ECAR. Examination of the pathways stimulated by (-)-isoproterenol, CL316243 and SR59230A for both ECAR and cAMP accumulation suggested that the cAMP pathway predominates in CHObeta3H cells while p38 MAPK is a major contributor to ECAR in CHObeta3L cells and was the sole contributor to responses to SR59230A. Western blots of p38 MAPK and Erk1/2 phosphorylation confirmed that MAPKs are activated in CHObeta3H and CHObeta3L cells by CL316243 and SR59230A but that SR59230A has much higher efficacy. In addition, p38 MAPK phosphorylation displayed differences in drug potency and efficacy between CHObeta3H and CHObeta3L cells related to inhibition of the response by cAMP. Thus CL316243 and SR59230A display reversed orders of efficacy for cAMP accumulation compared to Erk1/2 and p38 MAPK phosphorylation providing a strong indication of ligand-directed signaling.
UR - http://www.scopus.com/record/display.url?eid=2-s2.0-35548946776&origin=inward&txGid=wpKO6atOD83PI4Fscozu943%3a12
U2 - 10.1124/mol.107.03533
DO - 10.1124/mol.107.03533
M3 - Article
SN - 0026-895X
VL - 72
SP - 1359
EP - 1368
JO - Molecular Pharmacology
JF - Molecular Pharmacology
IS - 5
ER -